Nabriva Therapeutics plc

NBRVF · OTC
Analyze with AI
6/30/2023
3/31/2023
12/31/2022
9/30/2022
Assets
Cash & Equivalents$2,182$1,798$12,414$14,647
Short-Term Investments$0$0$0$0
Receivables$4,439$10,510$6,742$12,388
Inventory$0$9,027$9,676$17,333
Other Curr. Assets$73$123$123$121
Total Curr. Assets$9,952$23,694$31,104$47,563
Property Plant & Equip (Net)$246$263$280$293
Goodwill$0$0$0$0
Intangibles$1$2$3$7
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$379$379$378$377
Total NC Assets$626$644$661$677
Other Assets$0$0$0$0
Total Assets$10,578$24,338$31,765$48,240
Liabilities
Payables$14,026$6,978$5,431$3,895
Short-Term Debt$196$197$4,833$5,733
Tax Payable$0$0$0$0
Deferred Revenue$0$19,884$0$10,792
Other Curr. Liab.$944$939$1,291$1,220
Total Curr. Liab.$26,203$27,998$27,605$21,640
LT Debt$344$345$388$399
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$352$352$479$578
Total NC Liab.$696$697$867$977
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$26,899$28,695$28,472$22,617
Equity
Pref Stock$0$0$0$0
Common Stock$32$32$32$30
Retained Earnings-$673,623-$661,561-$652,861-$630,083
AOCI$27$27$27$27
Other Equity$0$0$0$0
Total Equity-$16,321-$4,357$3,293$25,623
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$10,578$24,338$31,765$48,240
Net Debt-$1,642-$1,256-$7,193-$8,515
Nabriva Therapeutics plc (NBRVF) Financial Statements & Key Stats | AlphaPilot